Medroxyprogesterone Acetate Injectable Suspension Injection, Suspension
Product Images NDC 24201-150

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate Injectable Suspension (NDC 24201-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Spl Img 01 Fig 1)

Figure 1 (Spl Img 01 Fig 1)
A logarithmic scale forest plot chart showing odds ratios with 95% confidence intervals from multiple studies, including Lee et al. (1987), Paul et al. (1989), WHO (1991), Shapiro et al. (2000), and Li et al. (2012). The chart compares odds ratios for increased risk associated with DMPA (medroxyprogesterone acetate) use, with values plotted horizontally and confidence intervals displayed as lines around squares representing the point estimates.*
FDA Label Image

Chemical Structure (Spl Img 02 Chem Struc)

Chemical Structure (Spl Img 02 Chem Struc)
Chemical structure diagram of medroxyprogesterone acetate, showing its steroid backbone with various functional groups including ketones, methyls, and acetoxy substituents.*
FDA Label Image

Figure 2 (Spl Img 04 Chart)

Figure 2 (Spl Img 04 Chart)
A chart illustrating methods of birth control categorized by effectiveness, showing the estimated pregnancies per 100 women per year for each method. It ranges from fewer than 1 pregnancy (implants, injections, intrauterine devices, sterilization) to no birth control with 85 or more pregnancies, including groups such as birth control pills, skin patches, vaginal rings, condoms, diaphragms, and behavioral methods.*
FDA Label Image

Vial Label (Spl Img 06 Vial Label)

Vial Label (Spl Img 06 Vial Label)
Label for Medroxyprogesterone Acetate Injectable Suspension, USP 150 mg per mL, an intramuscular injection. Single-dose 1 mL vial. Label includes dosage instructions to see prescribing information, shake before use, and store upright. Manufactured for Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.